DENTSPLY SIRONA Inc. – Consensus ‘buy’ rating and 2.5% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

DENTSPLY SIRONA Inc. which can be found using ticker (XRAY) now have 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $41.00 and $30.00 calculating the average target price we see $34.17. Given that the stocks previous close was at $33.33 this is indicating there is a potential upside of 2.5%. It’s also worth noting that there is a 50 day moving average of $30.96 and the 200 day MA is $36.72. The company has a market cap of 7.28B. The current share price for the company is: $34.35 USD

The potential market cap would be $7,460,799,438 based on the market consensus.

The company has a dividend yield of 3.36%. Other points of data to note are a P/E ratio of -, revenue per share of $18.45 and a 2.46% return on assets.

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions including dental equipment and dental and healthcare consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The Technologies & Equipment segment is engaged in designing, manufacturing and sales of the Company’s dental technology and equipment products and healthcare products. The T&E segment products include dental implants, computer-aided design/computer-aided manufacturing (CAD/CAM) systems, orthodontic aligners, imaging systems, treatment centers, instruments, as well as medical devices. The Consumables segment is engaged in designing, manufacturing and sales of the Company’s consumable products, which include various preventive, restorative, endodontic, and dental laboratory products. The Company manufactures and sells healthcare consumable products for urological applications.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search